29 Nov 2022

Monkeypox renamed mpox by WHO to avoid stigmatising language

10:52 am on 29 November 2022
Monkeypox virus particles, illustration. Monkeypox is a zoonotic virus from the Poxviridae family that causes monkeypox, a pox-like disease. At the centre of the monkeypox virus is a core nucleoprotein that contains the DNA (deoxyribonucleic acid) genome. This is surrounded by an outer envelope that is covered with surface tubules. This virus, which is found near rainforests in Central and West Africa causes disease in humans and monkeys, although its natural hosts are rodents. It is capable of human to human transmission. In humans it causes fever, swollen glands and a rash of fluid-filled blisters.

The virus formerly known as monkeypox Photo: AFP / Science Photo Library

Monkeypox will now be known as mpox, the World Health Organisation (WHO) has announced, after complaints over racist and stigmatising language linked to the virus's name.

The old term will be used alongside the new one for a year, before being phased out.

Mpox was decided on after lengthy discussions between experts, countries and the general public.

It can easily be used in English as well as other languages, the WHO said.

Human monkeypox was first identified in 1970 and named after the disease caused by the virus was discovered in captive monkeys more than a decade before.

Since then, the WHO has introduced advice on naming diseases.

It stresses the need to minimise unnecessary negative impact on trade, travel, tourism or animal welfare, and to avoid causing offence to any cultural, social, national or ethnic groups.

During the Covid-19 pandemic it recommended that variants were referred to using letters of the Greek alphabet because they were "non-stigmatising" and easy to pronounce.

This year, there has been unusual spread of mpox virus - a member of the same family of viruses as smallpox - in many countries outside central and west Africa, where it is often found.

Illustration of test tubes labs labelled Monkeypox virus test.

Photo: AFP / Joao Luiz Bulcao / Hans Lucas

In July, the WHO declared a global health emergency because of the worldwide surge in people developing symptoms, including a high fever and skin lesions or rash.

Media caption,

Cases of the disease have been declining for several months now, but more than 100 different countries have been affected in 2022 - prompting huge demand for vaccine supplies to protect those most at risk.

The US, Brazil, Spain, France and the UK have reported the highest total number of mpox cases this year. Globally, there have been 50 deaths from the virus.

Since May, the UK has reported more than 3500 cases but a rollout of vaccines to vulnerable groups helped drive down numbers following a peak in July. Most people affected were men who have sex with men.

In New Zealand, 36 cases were confirmed by 24 November. Of those 26 were identified as community transmission and 10 were acquired overseas.

- BBC / RNZ

Get the RNZ app

for ad-free news and current affairs